Abstract
Zika virus (ZIKV) infection is an emerging global health concern, and diagnostic recommendations are currently developing based on new information. Several case or small sample size studies using both urine and blood samples suggest that ZIKV RNA can be detected at higher levels and for a longer time after onset of infection in urine compared to blood. We recommend that urine and serum collection for molecular testing be a standard part of evaluating patients for ZIKV infection, and that urine is a good alternative testing sample when blood collection is problematic.
Similar content being viewed by others
Introduction
Infection with Zika virus (ZIKV) is of growing concern since it is suspected with causing brain defects in newborns including microcephaly [1] and, more recently, having potential neurological and autoimmune complications, such as Guillian–Barré syndrome and acute disseminated encephalomyelitis (ADEM) [2, 3]. ZIKV is anticipated to spread throughout the United States and globally within the next year, as it is transmitted by infected Aedes mosquitos, which are present on all continents except Antarctica. ZIKV has also been reported to be transmitted sexually [4, 5].
ZIKV infection is characterized by mild fever, arthralgia, myalgia, headache, retroorbital pain, conjunctivitis, and cutaneous maculopapular rash. It is difficult to diagnose ZIKV infection based on clinical signs and symptoms alone due to overlaps with other arboviruses that are endemic to similar areas [6], and infection is asymptomatic in most (60–80 %) adult healthy patients [7, 8].
Methods
Search strategy and selection criteria
References for this article were identified through searches of PubMed for articles published from 1973 to 10 April 2016, by use of the terms “Zika virus”, “ZIKV”, “urine”, “saliva”, “semen”, “diagnosis”. Articles resulting from these searches and relevant references cited in those articles were reviewed.
Current Zika virus diagnostic criteria
ZIKV infection can also be misdiagnosed during the acute (viremic) phase because of nonspecific flu signs and symptoms. At this time, the Food and Drug Administration (FDA) has issued emergency use authorization for two commercial tests for ZIKV detection: the RealStar® Zika virus RT-PCR Kit (available from Altona Diagnostics) and the Zika virus RNA Qualitative Real-Time RT-PCR (available from Quest Diagnostic Tests). There are currently several diagnostic tests available for ZIKV. Quantitative reverse transcription PCR (RT-PCR) of ZIKV RNA in serum or plasma samples is the primary approach. However, this method can give a negative result as soon as 3–5 days after symptom onset [8, 9], which does not exclude ZIKV infection. IgM antibody detection by ELISA can be done 4 days after onset but cannot distinguish between ZIKV from Dengue Fever virus, Yellow Fever virus, and possibly to vaccines against flaviviruses [8, 10–12]. Plaque-reduction neutralization test (PRNT) can measure virus-specific antibodies, but cross-reactivity also exists.
Advantages of non-invasive sample collections
Urine, saliva, nasopharygeal, and/or buccal (cheek swab) testing are non-invasive and are an attractive sample for diagnostic testing in which blood collection can be difficult. This may include young children, neonates, elderly, patients with hemorrhagic syndromes, patient refusal, or patients who present with small, dehydrated, or elusive veins. Sample collection can also be done at field locations where trained medical personal or facilities may be lacking, and allow for self-collection within communities for surveillance or epidemiology studies during an outbreak. Lastly, ZIKV has been reported to be transmitted through blood donation [13].
Diagnosis of other viral infections in urine and saliva samples has been reported for human immunodeficiency virus (HIV), Hepatitis A, B, and C, and rubella [14–20], and more recently in other flaviviruses, West-Nile virus (WNV) [21–23] and Dengue (DENV) serotypes -1, -2, -3, and -4 [24–35]. WNV can be detected longer in urine than serum [21] and can be isolated from urine [22, 23]. Some studies also suggest that like WNV, DENV can be detected for a longer time in urine than saliva or serum [25, 29, 31, 32].
Urine may have a longer detection window for molecular diagnosis than serum or plasma samples
Kutsuna and colleagues first reported that ZIKV RNA could be detected by RT-PCR in the urine but not the serum of an infected patient [36]. ZIKV has also been reported to be detected in urine of adults [37–39] and at least one neonate [37]. It is also detectable in the amniotic fluid (comprising mostly of fetal urine) of fetuses with microcephaly or fetal brain abnormalities [40, 41]. The diagnostic utility of urine was best characterized in a more extensive study of six infected patients from a 2014 ZIKV outbreak in New Caledonia, from which urine and serum from the same patients at multiple comparable time points were investigated [38]. Importantly, ZIKV is detectable for a longer time frame post-infection in urine than serum (7 or more days after becoming undetectable in serum) [38] and at a higher viral load in urine (up to 220 × 106 copies/mL) than in corresponding serum samples (up to 8.1 × 106 copies/mL) [42]. Other groups have also reported either a longer detection window or an increased ZIKV detection in urine over other bodily fluids on a case study basis (Tables 1 and 2) [30, 37, 43–46], although there have been cases where ZIKV was detected in the serum but not urine [47]. A larger cohort of paired serum and urine samples would be beneficial to support these findings. ZIKV was even detected in urine up to 15–21 days after onset of Guillian–Barré syndrome in two patients; ZIKV was not detectable in plasma or CSF for either patient and detection may not be related to neurological symptoms [45]. Isolation and sequencing of ZIKV from urine samples has also been documented [39, 44, 48]. The Centers for Disease Control and Prevention (CDC) now recommends that urine samples be collected <14 says after onset of symptoms in patients with suspected ZIKV infection and that molecular testing of urine be performed in conjunction with serum testing [49]. The CDC Trioplex rRT-PCR assay is the only ZIKV diagnostic test authorized by the FDA for urine. It is important to note that urine may not work as well as blood samples for assays other than RT-PCR, including IgM assays. Lastly, the majority of studies used only the primers described in Lanciotti et al. [12].
Other non-invasive samples
ZIKV has also been reported to be detected in saliva of both neonates and adults [37, 39, 50] and ZIKV can be isolated from saliva [39]. In a study comparing paired saliva and serum samples (n = 182) from the 2013–2014 French Polynesia outbreak, saliva had increased rate of molecular detection but not increased window of detection [50]. The authors noted that ZIKV RNA could be negative in some saliva samples while still positive in blood samples, and since blood samples are required for other laboratory tests that saliva could not act as a replacement.
ZIKV has also been detected in semen of a few men, and supports the idea that ZIKV can be spread by sexual transmission [5, 51–53]. In the few cases ZIKV has been evaluated in semen, the infectious load was considerably high and persisted over 8–10 weeks past symptom onset [5, 51–53]. Viral load was several logs of magnitude higher than corresponding urine samples, and not detectable at all in serum. This area merits more investigation, especially given the potential for ZIKV sexual transmission and poor pregnancy outcomes, but may be a good option for late diagnosis in men.
Implications for policy and practice
Taken together these studies suggests that urine samples should be collected in addition to blood for molecular testing of ZIKV especially if samples are not collected within first few days of symptom onset. This may result in an increased number of laboratory confirmed cases. Urine samples may also allow for easier monitoring of potentially exposed individuals who are at high risk for ZIKV infection complications, such as pregnant women, or individuals were collection of blood is problematic. Lastly, molecular testing of urine samples may aid in large epidemiological or surveillance studies.
Conclusion
Several studies have now been published using paired urine and serum or plasma samples, suggesting that overall, ZIKV RNA can be detected at higher levels and for a longer time after onset of infection in urine compared to serum. Semen may also allow late detection in men. Together, this suggests that ZIKV may be shed through the urine and may have a reservoir or even be actively replicating in the genito-urinary tract. In summary, the results of these studies suggests that urine samples should be considered for collection in addition to blood for molecular testing of ZIKV, and may result in an increased number of laboratory confirmed cases. Urine samples may also allow for easier monitoring of potentially exposed individuals, especially pregnant women, couples wanting to conceive, or individuals with suspicious symptoms.
References
Schnirring L (2015) Zika virus spreads to more countries. In: Center for Infectious Disease Research and Policy (ed) U. of Minnesota Academic Health Center
Oehler E, Watrin L, Larre P et al (2014) Zika virus infection complicated by Guillain-Barre syndrome—case report, French Polynesia, December 2013. Euro Surveill 19(9):20720
American Academy of Neurology (2016) Zika virus may now be tied to another brain disease. https://www.aan.com/PressRoom/Home/PressRelease/1451. Accessed 4 Dec 2016
Hearn P, Atkinson B, Hewson R, Brooks T (2014) Identification of the first case of imported Zika Fever to the UK: a novel sample type for diagnostic purposes and support for a potential non-vectorborne route of transmission. Am J Trop Med Hyg 91(5):62–63
Musso D, Roche C, Robin E, Nhan T, Teissier A, Cao-Lormeau VM (2015) Potential sexual transmission of Zika virus. Emerg Infect Dis 21(2):359–361
Fauci AS, Morens DM (2016) Zika virus in the Americas—yet another arbovirus threat. New Engl J Med 374(7):601–604
Duffy MR, Chen TH, Hancock WT et al (2009) Zika virus outbreak on Yap Island, Federated States of Micronesia. New Engl J Med 360(24):2536–2543
European Centre for Disease Prevention and Control (2015) Factsheet for health professionals. http://ecdc.europa.eu/en/healthtopics/zika_virus_infection/factsheet-health-professionals/Pages/factsheet_health_professionals.aspx. Accessed 24 Dec 2015
World Health Organization (2016) Zika virus and potential complications. http://www.wpro.who.int/outbreaks_emergencies/zika_virus/en/. Accessed 18 Mar 2016
Faye O, Faye O, Diallo D, Diallo M, Weidmann M, Sall AA (2013) Quantitative real-time PCR detection of Zika virus and evaluation with field-caught mosquitoes. Virol J 10:311
Hayes EB (2009) Zika virus outside Africa. Emerg Infect Dis 15(9):1347–1350
Lanciotti RS, Kosoy OL, Laven JJ et al (2008) Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 14(8):1232–1239
Musso D, Nhan T, Robin E et al (2014) Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 19(14):20761
Elsana S, Sikuler E, Yaari A et al (1998) HCV antibodies in saliva and urine. J Med Virol 55(1):24–27
Joshi MS, Chitambar SD, Arankalle VA, Chadha MS (2002) Evaluation of urine as a clinical specimen for diagnosis of hepatitis a. Clin Diagn Lab Immunol 9(4):840–845
Numata N, Ohori H, Hayakawa Y, Saitoh Y, Tsunoda A, Kanno A (1993) Demonstration of hepatitis C virus genome in saliva and urine of patients with type C hepatitis: usefulness of the single round polymerase chain reaction method for detection of the HCV genome. J Med Virol 41(2):120–128
Perry KR, Parry JV, Vandervelde EM, Mortimer PP (1992) The detection in urine specimens of IgG and IgM antibodies to hepatitis A and hepatitis B core antigens. J Med Virol 38(4):265–270
Terada K, Niizuma T, Kataoka N, Niitani Y (2000) Testing for rubella-specific IgG antibody in urine. Pediatr Infect Dis J 19(2):104–108
Luo W, Masciotra S, Delaney KP et al (2013) Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort. J Clin Virol 58(Suppl 1):e113–118
Frerichs RR, Silarug N, Eskes N et al (1994) Saliva-based HIV-antibody testing in Thailand. Aids 8(7):885–894
Barzon L, Pacenti M, Franchin E et al (2013) Excretion of West Nile virus in urine during acute infection. J Infect Dis 208(7):1086–1092
Barzon L, Pacenti M, Franchin E et al (2014) Isolation of West Nile virus from urine samples of patients with acute infection. J Clin Microbiol 52(9):3411–3413
Papa A, Testa T, Papadopoulou E (2014) Detection of West Nile virus lineage 2 in the urine of acute human infections. J Med Virol 86(12):2142–2145
Anders KL, Nguyet NM, Quyen NT et al (2012) An evaluation of dried blood spots and oral swabs as alternative specimens for the diagnosis of dengue and screening for past dengue virus exposure. Am J Trop Med Hyg 87(1):165–170
Andries AC, Duong V, Ly S et al (2015) Value of routine Dengue diagnostic tests in urine and saliva specimens. PLoS Negl Trop Dis 9(9):e0004100
Balmaseda A, Saborio S, Tellez Y et al (2008) Evaluation of immunological markers in serum, filter-paper blood spots, and saliva for dengue diagnosis and epidemiological studies. J Clin Virol 43(3):287–291
Chakravarti A, Matlani M, Jain M (2007) Immunodiagnosis of dengue virus infection using saliva. Curr Microbiol 55(6):461–464
Chuansumrit A, Chaiyaratana W, Tangnararatchakit K, Yoksan S, Flamand M, Sakuntabhai A (2011) Dengue nonstructural protein 1 antigen in the urine as a rapid and convenient diagnostic test during the febrile stage in patients with dengue infection. Diagn Microbiol Infect Dis 71(4):467–469
Hirayama T, Mizuno Y, Takeshita N et al (2012) Detection of dengue virus genome in urine by real-time reverse transcriptase PCR: a laboratory diagnostic method useful after disappearance of the genome in serum. J Clin Microbiol 50(6):2047–2052
Korhonen EM, Huhtamo E, Virtala AM, Kantele A, Vapalahti O (2014) Approach to non-invasive sampling in dengue diagnostics: exploring virus and NS1 antigen detection in saliva and urine of travelers with dengue. J Clin Virol 61(3):353–358
Ma X, Zhen W, Yang P et al (2014) First confirmation of imported dengue virus serotype 2 complete genome in urine from a Chinese traveler returning from India. Virol J 11:56
Mizuno Y, Kotaki A, Harada F, Tajima S, Kurane I, Takasaki T (2007) Confirmation of dengue virus infection by detection of dengue virus type 1 genome in urine and saliva but not in plasma. Trans R Soc Trop Med Hyg 101(7):738–739
Poloni TR, Oliveira AS, Alfonso HL et al (2010) Detection of dengue virus in saliva and urine by real time RT-PCR. Virol J 7:22
Vazquez S, Cabezas S, Perez AB et al (2007) Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections. Int J Infect Dis 11(3):256–262
Yap G, Sil BK, Ng LC (2011) Use of saliva for early dengue diagnosis. PLoS Negl Trop Dis 5(5):e1046
Kutsuna S, Kato Y, Takasaki T et al (2014) Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014 [corrected]. Euro Surveill 19(4):20683
Besnard M, Lastere S, Teissier A, Cao-Lormeau V, Musso D (2014) Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill 19(13):20751
Gourinat AC, O’Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M (2015) Detection of Zika virus in urine. Emerg Infect Dis 21(1):84–86
Korhonen EM, Huhtamo E, Smura T, Kallio-Kokko H, Raassina M, Vapalahti O (2016) Zika virus infection in a traveller returning from the Maldives, June 2015. Euro Surveill 21(2):30107
Calvet G, Aguiar RS, Melo AS et al (2016) Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 16(6):653–660
Oliveira Melo AS, Malinger G, Ximenes R, Szejnfeld PO, Alves Sampaio S, de Bispo Filippis AM (2016) Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: Tip of the iceberg? Ultrasound Obstet Gynecol 47(1):6–7
European Centre for Disease Prevention and Control (2016) Rapid risk assessment. Zika virus disease epidemic: potential association with microcephaly and Guillain–Barré syndrome. ECDC, Stockholm
de M CR, Cirne-Santos C, Meira GL et al (2016) Prolonged detection of Zika virus RNA in urine samples during the ongoing Zika virus epidemic in Brazil. J Clin Virol 77:69–70
Fonseca K, Meatherall B, Zarra D et al (2014) First case of Zika virus infection in a returning Canadian traveler. Am J Trop Med Hyg 91(5):1035–1038
Roze B, Najioullah F, Ferge JL et al (2016) Zika virus detection in urine from patients with Guillain-Barre syndrome on Martinique, January 2016. Euro Surveill 21(9):30154. doi:10.2807/1560-7919.ES.2016.21.9.30154
Shinohara K, Kutsuna S, Takasaki T et al (2016) Zika fever imported from Thailand to Japan, and diagnosed by PCR in the urines. J Travel Med 23(1):tav011. doi:10.1093/jtm/tav011
Brasil P, Pereira JP Jr, Raja Gabaglia C et al (2016) Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. New Engl J Med. doi:10.1056/NEJMoa1602412
Barzon L, Pacenti M, Berto A et al (2016) Isolation of infectious Zika virus from saliva and prolonged viral RNA shedding in a traveller returning from the Dominican Republic to Italy, January 2016. Euro Surveill 21(10). doi:10.2807/1560-7917.ES.2016.21.10.30159
Interim Guidance for Zika Virus Testing of Urine—United States. MMWR Morb Mortal Wkly Rep 2016, 65. doi:10.15585/mmwr.mm6518e1
Musso D, Roche C, Nhan TX, Robin E, Teissier A, Cao-Lormeau VM (2015) Detection of Zika virus in saliva. J Clin Virol 68:53–55
Rowland A, Washington CI, Sheffield JS, Pardo-Villamizar CA, Segars JH (2016) Zika virus infection in semen: a call to action and research. J Assist Reprod Genet 33(4):435–437
Mansuy JM, Dutertre M, Mengelle C et al (2016) Zika virus: High infectious viral load in semen, a new sexually transmitted pathogen? Lancet Infect Dis 16(4):405
Barry A, Pasco H, Babak A et al (2016) Detection of Zika virus in semen. Emerg Infect Dis J 22(5):940
Maria AT, Maquart M, Makinson A et al (2016) Zika virus infections in three travellers returning from South America and the Caribbean respectively, to Montpellier, France, December 2015 to January 2016. Euro Surveill 21(6):30131
Atkinson B, Hearn P, Afrough B et al (2016) Detection of Zika virus in semen. Emerg Infect Dis 22(5):940
Dupont-Rouzeyrol M, Biron A, O’Connor O, Huguon E, Descloux E (2016) Infectious Zika viral particles in breastmilk. Lancet 387:1051
Petersen EE, Staples JE, Meaney-Delman D et al (2016) Interim guidelines for pregnant women during a Zika virus outbreak—United States, 2016. MMWR Morb Mortal Wkly Rep 65(2):30–33
Fleming-Dutra KE, Nelson JM, Fischer M et al (2016) Update: interim guidelines for health care providers caring for infants and children with possible Zika virus infection—United States, February 2016. MMWR Morb Mortal Wkly Rep 65(7):182–187
Funding
This study was funded in part by the Maureen and Ronald Hirsch family philanthropic contribution.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Drs. Lamb and Chancellor have a pending provision patent on urine biomarkers using proteins and RNA in urine for infectious and other urologic diseases. For the remaining authors none were declared. No funding was received for this work.
Ethical approval
This article does not contain any studies with human participants and animals performed by any of the authors.
Informed consent
None.
Rights and permissions
About this article
Cite this article
Lamb, L.E., Bartolone, S.N., Kutluay, S.B. et al. Advantage of urine based molecular diagnosis of Zika virus. Int Urol Nephrol 48, 1961–1966 (2016). https://doi.org/10.1007/s11255-016-1406-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-016-1406-9